Pharmacoinvasive Approach with Streptokinase in Low to Intermediate Risk ST-Elevation Myocardial Infarction Patients: Insights from the Tamil Nadu-STEMI Initiative

Am J Cardiovasc Drugs. 2019 Oct;19(5):517-519. doi: 10.1007/s40256-019-00327-7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Female
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • India
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / methods
  • Risk
  • ST Elevation Myocardial Infarction / drug therapy*
  • Streptokinase / therapeutic use*
  • Thrombolytic Therapy / methods

Substances

  • Fibrinolytic Agents
  • Streptokinase